Dafna Yahav

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

Mical Paul, George L. Daikos, Emanuele Durante‐Mangoni et al. · The Lancet Infectious Diseases · 2018 · 593 citations

Severe Infections, Health Sciences, Antibiotics +9

Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial

Dafna Yahav, Erica Franceschini, Fidi Koppel et al. · Clinical Infectious Diseases · 2018 · 387 citations · Full text

Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer

Amir Massarweh, Noa Eliakim‐Raz, Amos Stemmer et al. · JAMA Oncology · 2021 · 282 citations · Full text

Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia

Steven Y. C. Tong, David Chien Lye, Dafna Yahav et al. · JAMA · 2020 · 261 citations · Full text

Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity

Dafna Yahav, Dana Yelin, Isabella Eckerle et al. · Clinical Microbiology and Infection · 2020 · 238 citations · Full text

Viral Persistence, Virus Epidemiology, Viral Diagnostics +8